Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for inducing an M1 dominated immune response and pharmaceutical compositions

Method for inducing an M1 dominated immune response and pharmaceutical compositions

US Patent 11389475 · Granted Jul 19, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

II-key/antigenic epitope hybrid peptide vaccines2016
Ii-key/HER-2/neu hybrid cancer vaccine2014
Ii-key/antigenic epitope hybrid peptide vaccines2014
Human papillomavirus / Ii-Key hybrids and methods of use2014
Ii-key/Her-2/neu hybrid cancer vaccine2011
Hybrid peptides modulate the immune response2009
Hybrid peptides modulate the immune response2007
Ii-Key/antigenic epitope hybrid peptide vaccines2007
Ii peptide therapeutics to enhance antigen presentation2004
Hybrid peptides modulate the immune response2002
MHC class II antigen presenting cells containing oligonucleotides which inhibit 2002
Ii peptide therapeutics to enhance antigen presentation1999